Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme. (24th March 2022) - Challapalli, A.; Watkins, S.; Cogill, G.; Stewart, G.; Ellis, S.; Sykes, A.; Nobes, J.; Yip, K.; Barthakur, U.; Board, R.; Gadve, A.; O'Toole, L.; et al.